Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Daiichi Sankyo Appoints Global Head, Oncology R&D | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Daiichi Sankyo Appoints Global Head, Oncology R&D

Yver to lead all global R&D across the oncology therapeutic area

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Antoine Yver, MD, MSc, has been appointed global head, Oncology Research and Development, Daiichi Sankyo, Inc. In this newly created role, Dr. Yver will have responsibility for leading all global R&D across the oncology therapeutic area including external investments, internal pipeline decisions, and resourcing requirements. He reports to Glenn Gormley, MD, Ph.D., senior executive officer and global head, R&D, Daiichi Sankyo Co., Ltd. and chairman of the board and president, Daiichi Sankyo, Inc.
 
Dr. Yver joins the company from AstraZeneca, where he most recently served as senior vice president and head of Oncology, Global Medicines Development, and Global Medicines Development China Lead across all therapeutic areas. Prior to joining AstraZeneca in 2009, he held several international oncology drug development positions at Merck/Schering-Plough, Johnson & Johnson and Rhône-Poulenc Rorer/Aventis.
 
“Antoine brings a strong track record of extensive scientific leadership in many facets of global oncology pharmaceutical research and development along with tremendous passion for science and patients,” said Dr. Gormley. “We are confident that Antoine will provide great leadership and strategic insights in this new role, which underscores Daiichi Sankyo’s commitment to the fight against cancer.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics